Xeris Pharmaceuticals



Ebit تغيير تاريخ
Adcock Ingram Holdings ZAR 541.46M 52.57M 2023-06
Celltrion KRW 196.4B 11.28B 2024-12
Cspc Pharmaceutical CNY 765.94M 131.97M 2024-12
Dianthus Therapeutics USD -31916000 2.02M 2024-12
Ecofibre AUD 3.42M 14.66M 2023-06
Eli Lilly USD 5.63B 3.88B 2024-12
Kangmei Pharma CNY -3262057.35 15.91M 2024-09
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 123.33M 85.87M 2024-12
Malin Corporation EUR -2200000 800K 2023-06
Medical Developments International AUD -12124000 3.97M 2023-06
Neuren Pharmaceuticals AUD 171.1M 159.25M 2024-12
Organigram Holdings CAD -11305000 11.59M 2024-12
Pacira USD 56.14M 7.23M 2024-12
Perrigo USD 193.9M 11.5M 2024-12
Pharma Mar EUR 4.89M 588K 2024-12
Qiagen NV USD 159.4M 10.4M 2024-12
Sartorius EUR 79.8M 44M 2024-09
Sino Biopharmaceutical CNY 3.42B 453.21M 2023-06
Supernus Pharmaceuticals USD 48.3M 19.4M 2024-12
Tilray USD -42218000 5.65M 2024-11
Zz Pientze Pharmaceu 1.13B 244.34M 2024-09



Xeris Pharmaceuticals - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Apr 2025.